ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO1011

Prevalence and Progression of Kidney Diseases Among Ethiopian Immigrants Compared with Other Immigrant and Native Populations in Israel

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Einbinder, Yael, Meir Medical Center, Kfar Saba, Central, Israel
  • Hornik-Lurie, Tzipi, Meir Medical Center, Kfar Saba, Central, Israel
  • Cohen - Hagai, Keren, Meir Medical Center, Kfar Saba, Central, Israel
  • Benchetrit, Sydney, Meir Medical Center, Kfar Saba, Central, Israel
  • Karpati, Tomas, Holon Institute of Technology, Holon, Israel
Background

The worldwide prevalence of kidney disease in the Ethiopian population is unknown. This study assessed the prevalence of CKD and risk-factors for progression among Ethiopian immigrants compared to Soviet Union immigrants, as well as Israeli-born Jewish and Arab population.

Methods

The study included all people above 25 years old who were insured by Clalit Health Services from 01/01/2007 until 31/12/2017, and had more than two plasma creatinine measurements at least 28 days apart, which demonstrated similar CKD stage. Follow-up was until 31/12/2020. Primary outcome was at least 50% decrease in estimated glomerular filtration rate (eGFR) calculated with CKD-epi equation. Cox regression model was used to analyze risk-factors for CKD progression.

Results

The study included 1,734,501 people, of whom 41,260 (2.4%) were Ethiopian immigrants, mean age 44.8±16.6 years, baseline eGFR 111.1±16.5 ml/min/1.73m2; 273,476 (15.8%) former Soviet Union immigrants, mean age 56.3±18.1 years, baseline eGFR 88.2±22.5 ml/min/1.73m2; 366,789 (21.1%) native Israeli Arabs, mean age 42.5±14.5 years, baseline eGFR 107.9±18.8 ml/min/1.73m2, and 1,052,976 (60.7%) native Israeli Jews, mean age 43.1±14.3 years, baseline eGFR 102.6±18.7 ml/min/1.73m2. (p<0.001 for age and eGFR). Decrease in eGFR ≥50% was documented in 38,913 (2.2%) people: 573 (1.4%) were Ethiopian immigrants. Cox regression model was performed in three age groups: Ethiopian ethnicity was associated with higher risk for CKD progression in the young group (<50 years), HR 1.70 (95% CI: 1.54-1.90, p <0.001), but had no effect in the 50 to 70 years age group, HR 1.14 (95% CI: 1.05-1.24, p =0.098) and had a protective effect in the older, ≥70 years group, HR 0.62 (95% CI: 0.57-0.68, p <0.001).

Conclusion

Young Ethiopian immigrants had higher risk for CKD progression which was absent among older Ethiopian immigrants, suggesting a genetic/familial etiology or adaptive factors. Further research is desirable.